| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | 1 | — | — | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 30.32 | 21.43 | 25.24 | 19.68 |
| Receivables | 14.20 | 18.15 | 15.86 | 13.12 |
| Inventory | 0.16 | 0.20 | 2.83 | 2.05 |
| Other | 219.08 | 192.62 | 228.11 | 178.92 |
| 267.22 | 237.28 | 278.37 | 221.82 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 2.57 | 1.36 | 2.17 | 2.04 |
| ST’ Debt | — | — | — | — |
| Other | 220.02 | 194.38 | 228.48 | 179.84 |
| 241.34 | 223.64 | 259.72 | 208.39 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 42.76 | 37.11 | — | — |
—
|
| ’25 | 34.85 | 30.12 | 36.25 | 39.31 |
140.54
|
| ’24 | 31.65 | 28.04 | 29.30 | 30.79 |
119.79
|
| ’23 | 33.06 | 30.42 | 29.33 | 26.26 |
119.08
|
| ’22 | 24.33 | 20.30 | 21.90 | 29.29 |
95.83
|
| ’21 | 19.80 | 17.17 | 17.98 | 21.11 |
76.06
|
| ’20 | 18.95 | 14.12 | 16.02 | 16.43 |
65.51
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.71 | 4.47 | — | — |
—
|
| ’25 | 2.00 | 3.16 | 5.77 | 11.29 |
22.22
|
| ’24 | (3.95) | 2.23 | 1.33 | 9.78 |
9.39
|
| ’23 | 4.59 | 1.51 | 5.74 | 7.07 |
18.90
|
| ’22 | 2.53 | 4.95 | (0.52) | 6.72 |
13.67
|
| ’21 | (1.36) | (0.54) | 0.75 | 2.52 |
1.38
|
| ’20 | (3.40) | 3.05 | 2.65 | (0.06) |
2.24
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (5.47) | 0.66 | — | — |
—
|
| ’25 | (7.31) | (0.75) | (6.77) | 6.86 |
(7.97)
|
| ’24 | (7.33) | (3.90) | (1.88) | 6.27 |
(6.85)
|
| ’23 | 2.70 | (0.93) | 2.97 | (2.11) |
2.64
|
| ’22 | 1.09 | 1.55 | (4.07) | 5.58 |
4.84
|
| ’21 | (3.87) | (2.73) | (25.63) | (24.03) |
(28.42)
|
| ’20 | (6.31) | 2.25 | (5.22) | (5.26) |
(14.54)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.02 | (0.15) | — | — |
—
|
| ’25 | (0.09) | (0.22) | (0.19) | 0.03 |
(0.48)
|
| ’24 | (0.01) | (0.17) | (0.15) | (0.12) |
(0.45)
|
| ’23 | 0.02 | (0.18) | (0.10) | (0.14) |
(0.42)
|
| ’22 | (0.15) | (0.29) | (0.22) | (0.05) |
(0.72)
|
| ’21 | (0.08) | 0.20 | 0.28 | (0.22) |
0.16
|
| ’20 | (0.11) | (0.25) | (0.30) | (0.36) |
(1.03)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 4.87 | 6.31 | 6.89 | 7.63 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 10.52 | 17.14 | 10.52 | 12.74 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 501 | 581 | 635 | 641 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.19 | 0.20 | 0.19 | 0.22 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 95.83 | 119.08 | 119.79 | 140.54 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 65.23% | 71.83% | 68.54% | 67.51% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (14.35) | (9.10) | (10.84) | (12.47) | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (14.98%) | (7.65%) | (9.05%) | (8.88%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (14.47) | (9.21) | (11.77) | (13.13) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.41 | 21.32 | 23.88 | 28.85 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.76 | 5.38 | 4.60 | 5.12 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | (0.72) | (0.42) | (0.45) | (0.48) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.68 | 0.85 | 0.36 | 0.81 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.44) | (0.73) | (0.62) | (1.10) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.24 | 0.12 | (0.26) | (0.29) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.21 | 8.66 | 7.57 | 7.21 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.12 | 22.14 | 26.05 | 27.43 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.99 | 1.68 | 2.05 | 1.84 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.32 | 1.04 | 1.24 | 1.31 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.20 | 1.48 | 1.93 | 2.12 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 50.79 | 73.65 | (33.76) | (37.42) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.67 | 18.90 | 9.39 | 22.22 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.83) | (16.26) | (16.23) | (30.19) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.84 | 2.64 | (6.85) | (7.97) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.09 | 25.88 | 13.64 | 18.65 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.76 | 4.28 | 5.71 | 63.28 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.75 | (26.03) | (15.72) | 38.04 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 145.07 | 191.66 | 197.32 | 197.80 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.39%) | (2.13%) | (2.67%) | (2.71%) | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4.29%) | (1.13%) | (3.70%) | (2.23%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (9.54%) | (5.47%) | (6.05%) | (6.64%) | ‡‡‡‡‡ | — | — |
ROE
|
Asure Software Inc. (ASUR), a HCM SaaS provider, has delivered impressive revenue growth from $35.5 million in 2016 to nearly $120 million in 2024, fueled by acquisitions and HCM demand. Yet this masks deep vulnerabilities: gross margins eroded sharply during COVID (dipping to 58%), revenue per employee fell 8% amid headcount bloat, and shares outstanding quadrupled, diluting per-share metrics and flipping free cash flow negative at -$14.7 million in 2024. Chronic unprofitability persists with EBT losses worsening to -$10.8 million, negative ROE, and high depreciation from deal accounting, despite a cleaner balance sheet with minimal debt.
Insider activity is mixed—more selling than buying in dollar terms, though CEO purchases at 2024 lows signal some confidence—while the stock trades at discounted valuations (PS 2x, EV/FCF -15.7x), trailing peers amid stagnant market cap despite 237% revenue gains since 2019. Analysts project 14% CAGR to $180 million by 2027 with path to breakeven, implying 75% upside, but history of execution slips, competition from Workday and ADP, and macro risks like 2020’s 10% plunge temper optimism.
This growth story teeters on flawless execution in a cutthroat SaaS arena—will platform unification and AI tailwinds deliver profits, or will dilution and cash burn prevail? A speculative bet for contrarians eyeing a turnaround.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.